intermediate-acting

intermediate-acting

adj
(Pharmacology) (of a drug) intermediate in its effects between long- and short-acting drugs. Compare long-acting, short-acting
References in periodicals archive ?
biz presents this most up-to-date research on Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019: Market Size, Trends, and Forecasts Research Report.
The Z-drugs, along with short-to intermediate-acting benzodiazepines and ramelteon (Rozerem), are first-line options for insomnia, according to American Academy of Sleep Medicine guidelines (J.
Neuromuscular blocking strategies for short procedures in patients with plasmacholinesterase deficiency have included using small doses of intermediate-acting non-depolarising agents (3), or reduced doses of suxamethonium (4).
In the case of insulin glargine, which is three times more expensive than the already approved intermediate-acting insulin NPH, "although each of the committees agreed that insulin glargine offered small incremental benefits over insulin NPH, all felt that unrestricted use at the price submitted was not cost-effective," the authors wrote.
1) Triamcinolone acetonide is considered an intermediate-acting steroid with a biologic half-life of 18 to 36 hours (2) and is available in suspension form, which provides an increased duration of action.
Short-acting and intermediate-acting insulins should be used in combination, and in the mornings and afternoons as necessary and appropriate; these parameters should be adjusted accordingly to achieve euglycemia.
In end-stage renal disease, regular insulin action may be as prolonged in effect as the intermediate-acting insulins.
According to a new market report published by Transparency Market Research "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, Modern and Human Insulin) - Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume), 2013 - 2019", the global insulin market was valued at USD 19.
Although the introduction of intermediate-acting muscle relaxants, such as vecuronium and atracurium, has helped to reduce its incidence, RNMB continues to occur (8).
was part of a baseline assessment of participants who were enrolled in a 24-week randomized clinical trial comparing insulin glargine to twice-daily intermediate-acting insulin, said Mr.
In the subcutaneous insulin group (n = 149), patients continued their regimen of two daily injections of mixed rapid-acting and intermediate-acting insulin.
Thus, many patients benefit from a change to insulin glargine, which provides a basal insulin without the peak action seen with intermediate-acting insulins such as NPH.

Full browser ?